OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
12.26
-0.13 (-1.05%)
Dec 31, 2025, 4:00 PM EST - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $228.53 million as of December 31, 2025. Its market cap has increased by 151.69% in one year.
Market Cap
228.53M
Enterprise Value
237.62M
1-Year Change
151.69%
Ranking
Category
Stock Price
$12.26
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $228.53M, an increase of 568.23%. That is a compound annual growth rate of 28.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 231.00M | 158.10% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 968.01B |
| Johnson & Johnson | 499.81B |
| AbbVie | 405.88B |
| UnitedHealth Group | 300.92B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.39B |
| Novo Nordisk | 227.80B |